Arcus Biosciences to Participate in the Goldman Sachs 43rd Annual Global Healthcare Conference

HAYWARD, Calif.–(BUSINESS WIRE)–May 31, 2022–. Arcus Biosciences (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on …

  • You already voted!
  • Read More